These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 30342482

  • 1. Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report.
    Fontana F, Alfano G, Leonelli M, Cerami C, Ligabue G, Spinella A, Citriniti G, Manzini CU, Ferri C, Cappelli G.
    BMC Nephrol; 2018 Oct 20; 19(1):276. PubMed ID: 30342482
    [Abstract] [Full Text] [Related]

  • 2. Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review.
    Margiotta DPE, Basta F, Batani V, Afeltra A.
    BMC Nephrol; 2018 Mar 07; 19(1):54. PubMed ID: 29514612
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
    Fließer EE, Korsten P, Koziolek MJ, Niewold TB, Patschan D, Müller GA, Patschan SA.
    Lupus; 2013 Dec 07; 22(14):1523-5. PubMed ID: 24014569
    [Abstract] [Full Text] [Related]

  • 4. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA, Houssiau F, Aranow C, D'Cruz DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW, Ginzler EM, BLISS-52 and -76 Study Groups.
    Lupus; 2013 Jan 07; 22(1):63-72. PubMed ID: 23263865
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Med Clin (Barc); 2013 Dec 21; 141(12):533-42. PubMed ID: 23622892
    [Abstract] [Full Text] [Related]

  • 6. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C, Karokis D, Liossis SC.
    Semin Arthritis Rheum; 2017 Jun 21; 46(6):788-790. PubMed ID: 27793432
    [Abstract] [Full Text] [Related]

  • 7. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
    Atisha-Fregoso Y, Malkiel S, Harris KM, Byron M, Ding L, Kanaparthi S, Barry WT, Gao W, Ryker K, Tosta P, Askanase AD, Boackle SA, Chatham WW, Kamen DL, Karp DR, Kirou KA, Sam Lim S, Marder B, McMahon M, Parikh SV, Pendergraft WF, Podoll AS, Saxena A, Wofsy D, Diamond B, Smilek DE, Aranow C, Dall'Era M.
    Arthritis Rheumatol; 2021 Jan 21; 73(1):121-131. PubMed ID: 32755035
    [Abstract] [Full Text] [Related]

  • 8. A case with good response to belimumab for lupus nephritis complicated by IgG4-related disease.
    Yamamoto M, Aochi S, Suzuki C, Nakamura S, Murakami R, Ogawa Y, Takahashi H.
    Lupus; 2019 May 21; 28(6):786-789. PubMed ID: 30917769
    [Abstract] [Full Text] [Related]

  • 9. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
    Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, Amoura Z, Yu X, Mok CC, Santiago MB, Saxena A, Green Y, Ji B, Kleoudis C, Burriss SW, Barnett C, Roth DA.
    N Engl J Med; 2020 Sep 17; 383(12):1117-1128. PubMed ID: 32937045
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
    Yu X, Chen N, Xue J, Mok CC, Bae SC, Peng X, Chen W, Ren H, Li X, Noppakun K, Gilbride JA, Green Y, Ji B, Liu C, Madan A, Okily M, Tang CH, Roth DA.
    Am J Kidney Dis; 2023 Mar 17; 81(3):294-306.e1. PubMed ID: 36058429
    [Abstract] [Full Text] [Related]

  • 11. Rituximab use as induction therapy for lupus nephritis: a systematic review.
    Stolyar L, Lahita RG, Panush RS.
    Lupus; 2020 Jul 17; 29(8):892-912. PubMed ID: 32486934
    [Abstract] [Full Text] [Related]

  • 12. Case report: successful treatment of membranous lupus nephritis with belimumab in an African female immigrant.
    De Scheerder MA, Boey O, Mahieu E, Vanuytsel J, Bogaert AM.
    Clin Rheumatol; 2016 Jun 17; 35(6):1649-53. PubMed ID: 26712500
    [Abstract] [Full Text] [Related]

  • 13. Belimumab for the treatment of pediatric patients with lupus nephritis.
    Stohl W, Kwok A.
    Expert Opin Biol Ther; 2023 Mar 17; 23(3):243-251. PubMed ID: 36750049
    [Abstract] [Full Text] [Related]

  • 14. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report.
    Danve A, Perry L, Deodhar A.
    Semin Arthritis Rheum; 2014 Oct 17; 44(2):195-7. PubMed ID: 25005336
    [Abstract] [Full Text] [Related]

  • 15. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR, Gordon C.
    BioDrugs; 2013 Apr 17; 27(2):85-95. PubMed ID: 23456653
    [Abstract] [Full Text] [Related]

  • 16. Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.
    de la Rubia Navarro M, Ivorra Cortés JR, Grau García E, Román Ivorra JA.
    Med Clin (Barc); 2022 Oct 14; 159(7):344-346. PubMed ID: 35811138
    [Abstract] [Full Text] [Related]

  • 17. Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).
    Binda V, Trezzi B, Del Papa N, Beretta L, Frontini G, Porata G, Fabbrini P, Pozzi MR, Messa P, Sinico RA, Moroni G.
    J Nephrol; 2020 Oct 14; 33(5):1019-1025. PubMed ID: 32002799
    [Abstract] [Full Text] [Related]

  • 18. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH, Chan TM.
    Int J Mol Sci; 2019 Dec 10; 20(24):. PubMed ID: 31835612
    [Abstract] [Full Text] [Related]

  • 19. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
    Steiger S, Ehreiser L, Anders J, Anders HJ.
    Front Immunol; 2022 Dec 10; 13():999704. PubMed ID: 36211360
    [Abstract] [Full Text] [Related]

  • 20. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N, D'Cruz DP.
    Expert Rev Clin Immunol; 2015 Feb 10; 11(2):195-204. PubMed ID: 25543845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.